KEGG: vco:VC0395_A2314
STRING: 345073.VC0395_A2314
The expression of recombinant Vibrio cholerae membrane proteins requires careful selection of expression systems. For VC0395_A2314/VC395_2854, researchers typically employ recombinant DNA techniques similar to those used for other V. cholerae membrane proteins. Using restriction enzyme fragments, genes encoding the target protein can be cloned into expression vectors and introduced into a V. cholerae strain of proven immunogenicity . When selecting an expression system, consider:
E. coli-based systems with specialized strains like BL21(DE3) or C41(DE3) for membrane protein expression
Homologous expression using attenuated V. cholerae strains
Cell-free expression systems for proteins that may be toxic to host cells
For optimal expression, control experiments comparing protein yields across different expression systems should be conducted, with detergent screening to identify conditions that maintain protein stability after extraction.
Isolation and purification of VC0395_A2314/VC395_2854 requires specialized techniques to maintain structural integrity. Based on approaches used for similar membrane proteins:
Membrane Fraction Isolation: Perform cell lysis followed by differential centrifugation to isolate membrane fractions
Detergent Screening: Test a panel of mild detergents (DDM, LDAO, OG) for efficient solubilization
Chromatography Selection: Employ sequential purification using:
Affinity chromatography (His-tag or custom antibody-based)
Size exclusion chromatography for final polishing
Stability Assessment: Monitor protein stability through dynamic light scattering and thermal shift assays
To preserve the native conformation, consider incorporating the protein into nanodiscs or liposomes after purification, similar to approaches used for other outer membrane proteins of V. cholerae .
Structural characterization of VC0395_A2314/VC395_2854 can be approached through multiple complementary techniques:
When designing structural studies, researchers should employ a multi-technique approach, starting with circular dichroism for initial secondary structure assessment, followed by more advanced techniques for detailed structural analysis . For membrane proteins like VC0395_A2314/VC395_2854, lipid composition during reconstitution significantly impacts structural integrity and should be systematically optimized.
When confronting contradictory data between in vitro binding studies and in vivo functional assays of VC0395_A2314/VC395_2854, researchers should implement a systematic approach:
Validate Expression Systems: Confirm that the protein maintains native conformation in both study types by using multiple antibodies targeting different epitopes
Control for Cofactors: Assess whether binding partners present in vivo but absent in vitro might explain functional differences
Design Quasi-experimental Studies: Implement removed-treatment designs (where the protein is initially present, then removed) to establish causality between protein presence and observed effects
Address Confounding Variables: Control for factors like lipopolysaccharide interaction, as membrane proteins often function in coordination with other membrane components
For robust reconciliation of contradictory data, implement a framework that:
Tests protein functionality in concentration gradients
Examines protein-protein interactions in complex membrane environments
Utilizes site-directed mutagenesis to identify critical functional residues
Compares results across multiple V. cholerae strains to control for strain-specific effects
To determine the role of VC0395_A2314/VC395_2854 in pathogenesis, researchers should employ multi-faceted approaches:
Genetic Manipulation Strategies:
Generate clean deletion mutants using allelic exchange
Create point mutations in predicted functional domains
Develop complementation strains to confirm phenotype specificity
Infection Models:
Infant mouse colonization model to assess in vivo fitness
Human intestinal organoid systems for host-pathogen interactions
Competitive index assays comparing wild-type and mutant strains
Molecular Interaction Studies:
Pull-down assays to identify host receptors
Surface plasmon resonance to quantify binding kinetics
Cross-linking studies to capture transient interactions
When designing these experiments, researchers should implement appropriate controls including using multiple V. cholerae strains to ensure observed phenotypes are not strain-specific . Statistical analysis should account for biological variability by employing sufficient biological replicates (minimum n=3) and appropriate statistical tests based on data distribution.
To investigate interactions between VC0395_A2314/VC395_2854 and other membrane components, researchers should implement a systematic experimental design:
In Silico Analysis:
Protein-protein interaction predictions based on structural modeling
Identification of potential binding domains through sequence analysis
Biochemical Verification:
Co-immunoprecipitation with antibodies against candidate interacting proteins
Blue native PAGE to preserve membrane protein complexes
Chemical cross-linking followed by mass spectrometry (XL-MS)
In Vivo Validation:
Bacterial two-hybrid systems adapted for membrane proteins
Förster resonance energy transfer (FRET) between fluorescently labeled proteins
Super-resolution microscopy to observe co-localization
When studying interactions with lipopolysaccharides, researchers should consider the possibility that both outer membrane proteins and oligosaccharide components may serve as co-receptors for bacteriophages, as observed with TolC . This experimental paradigm can provide insights into functional relationships between different membrane components.
To assess the immunogenicity of VC0395_A2314/VC395_2854 for vaccine development, researchers should implement a comprehensive evaluation strategy:
Epitope Mapping:
In silico prediction of B-cell and T-cell epitopes
Peptide array screening with sera from convalescent patients
Hydrogen/deuterium exchange mass spectrometry to identify exposed regions
Immunological Assessment:
ELISA to quantify antibody responses in animal models
ELISpot assays to enumerate antigen-specific T cells
Flow cytometry to characterize cellular immune responses
Protection Studies:
Challenge experiments in appropriate animal models
Passive transfer of antibodies to assess protection mechanisms
Mucosal immunity evaluation through secretory IgA measurement
When developing recombinant protein-based vaccines, researchers should consider that previous studies indicate toxoid-derived antitoxic immunity alone is insufficient for effective, long-lasting protection against cholera . Therefore, combining VC0395_A2314/VC395_2854 with other protective antigens may be necessary for robust immunity.
Membrane vesicles provide an excellent system to study proteins like VC0395_A2314/VC395_2854 in a near-native environment. To effectively apply vesicle isolation techniques:
Isolation Protocol Optimization:
Characterization Approaches:
Proteomic analysis using mass spectrometry to confirm protein presence
Western blotting with specific antibodies to quantify relative abundance
Dynamic light scattering to assess vesicle size distribution
Functional Assessment:
Binding assays with potential interaction partners
Transport studies if VC0395_A2314/VC395_2854 is predicted to have transporter activity
Lipidomic analysis to characterize the lipid environment
When isolating vesicles from V. cholerae, researchers should be aware that both double- and single-membrane vesicle structures exist , which may affect the orientation and functionality of the embedded proteins. Control experiments should verify protein orientation using protease accessibility assays.
Site-directed mutagenesis studies require careful experimental design and controls:
When analyzing the impact of mutations, researchers should consider examples from similar proteins like TolC, where specific amino acid residues (positions 78, 290, and 291) in the outside loops are critical for function . This approach can help identify functionally important domains in VC0395_A2314/VC395_2854.
When confronted with strain-specific variations in VC0395_A2314/VC395_2854 function:
Systematic Strain Comparison:
Sequence the gene across multiple strains to identify polymorphisms
Create phylogenetic trees to correlate sequence variations with functional differences
Perform complementation studies with variants from different strains
Environmental Context Analysis:
Assess protein function under varying conditions (pH, osmolarity, nutrient availability)
Evaluate interaction with strain-specific membrane components
Consider horizontal gene transfer history that might affect protein function
Statistical Approach:
When analyzing strain-specific differences, researchers should consider that mutations in surface-exposed regions of membrane proteins can significantly alter function, as observed in TolC variants that confer phage resistance . These principles can help explain functional variations of VC0395_A2314/VC395_2854 across different strains.
For comprehensive structure-function prediction of VC0395_A2314/VC395_2854:
Structure Prediction:
Utilize AlphaFold2 or RoseTTAFold for ab initio modeling
Perform molecular dynamics simulations in membrane environments
Validate models through comparison with experimental data
Functional Domain Identification:
Apply conserved domain database searches
Conduct evolutionary trace analysis to identify functionally important residues
Implement machine learning approaches trained on known membrane protein functions
Interaction Prediction:
Molecular docking to predict binding partners
Coevolution analysis to identify potential interaction interfaces
Protein-protein interaction network construction
When applying these approaches, researchers should integrate experimental validation at each step, as computational predictions alone may not capture the complexity of membrane protein interactions in the bacterial outer membrane environment.
Future research on VC0395_A2314/VC395_2854 should focus on:
Systems Biology Integration:
Multi-omics approaches combining transcriptomics, proteomics, and metabolomics
Network analysis to position VC0395_A2314/VC395_2854 within cellular pathways
Synthetic biology approaches to create minimal systems for functional validation
Advanced Structural Biology:
Time-resolved structural studies to capture conformational changes
In-cell structural biology to observe the protein in its native environment
Integration of computational and experimental approaches for dynamic modeling
Translational Applications:
Evaluation as a diagnostic biomarker for specific V. cholerae strains
Assessment as a vaccine antigen component
Exploration as a target for novel antibacterial compounds